WALTHAM, Mass.--(BUSINESS WIRE)--Aug. 10, 2006--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced the immediate availability of a new version (2.0) of the Electronic Case Submissions Module (ECSM). The ECSM, together with the Clintrace(TM) adverse event tracking and reporting system, provides a comprehensive solution for safety data collection, management and submission. The ECSM streamlines the exchange of electronic case safety information with regulatory agencies, affiliate offices and trading partners. Version 2.0 is designed to adhere to the FDA’s latest Electronic Submission Gateway (ESG) standards. The latest version of the ECSM takes advantage of features of the new FDA ESG and offers benefits including expanded submissions tracking and acknowledgements via integration with Clintrace, and enhanced application security.
